Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial - Yusuf, S; Teo, K; Anderson, C; Pogue, J; Dyal, L; Copland, I; Schumacher, H; Dagenais, G; Sleight, P (The Lancet (British edition), 2008)
Keywords: adverse effects; Aged; Angioedema; Angioedema - chemically induced; Angiotensin-Converting Enzyme Inhibitors; Angiotensin-Converting Enzyme Inhibitors - adverse effects; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Benzimidazoles; Benzimidazoles - adverse effects; Benzimidazoles - therapeutic use; Benzoates; Benzoates - adverse effects; Benzoates - therapeutic use; Blood pressure; Cardiovascular disease; Cardiovascular Diseases; Cardiovascular Diseases - prevention & control; chemically induced; Cough; Cough - chemically induced; Diabetes; Enzyme inhibitors; Female; Follow-Up Studies; Heart attacks; Humans; Hypotension; Hypotension - chemically induced; Internal Medicine; Kaplan-Meier Estimate; Kaplan-Meiers Estimate; Male; Medical and Health Sciences; Medical research; Medicin och hälsovetenskap; Mortality; Myocardial infarction; prevention & control; Risk Reduction Behavior; Single-Blind Method; Therapeutic Equivalency; therapeutic use